Predictors of AIS Unfavorable Outcomes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 592 participants.

Also called NCT06058884

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 592 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06058884
Other papers using this trial's data
  • Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial Scientific reports, 2024-03-12 DOI, PubMed 38472241, PMC10933394 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06058884. Randomized; no masking; primary purpose treatment. Start 2022-01-03 (actual); primary completion 2023-06-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Predictors of AIS Unfavorable Outcomes
Condition
Alteplase Adverse Reaction
Intervention (Drug)
Alteplase
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06058884
Content hash
8ce2df29e00ff9fb7922cb6b23b21a7c7629b30cf6ae8c7ef1510d77a1bb8145